WASHINGTON — New documents obtained by STAT outline how Medicare is planning to build out a sizable new bureaucratic infrastructure to handle its new power to negotiate drug prices and penalize drugmakers for price hikes.
In materials sent to lawmakers earlier this month, CMS proposes establishing a Medicare Drug Rebate and Negotiations Group with six divisions: